| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Immunovant CEO | President &COO | Chief Operating Officer
1 company
Venker Eric serves as a President &Immunovant CEO at ROIV. Across recent SEC filings that breaks down to 0 buys and 85 sells. Those positions are worth an estimated $58.4M at current prices.
Historically, Venker Eric's trades have earned a below-average insider score of 42/100 across 81 rated trades. Over a 12-month horizon, 16.1% of those trades were profitable, with an average 12-month return of -44.5%.
The biggest single holding is ROIV (~$58.4M) as President &Immunovant CEO. The recent filings there lean toward selling, a net 12,977,626 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 | ROIV Roivant Sciences Ltd. | President &COO | Sell | 5,107 | $3.84 | $19,610.88 | -0.4% | +2.7% | +115.8% | |
| Mar 30, 2022 | ROIV Roivant Sciences Ltd. | President &COO | Sell | 19,336 | $4.84 | $93,586.24 | -1.5% | -0.8% | +54.2% | |
| Mar 25, 2022 | ROIV Roivant Sciences Ltd. | President &COO | Sell | 80,045 | $5.06 | $405,027.70 | -5.8% | -6.4% | +39.0% |